P3‐163: Prevalence of cognitive impairment and dementia in a cohort of oldest old in Brazil: The Pietà study

Caramelli, Paulo; Teixeira, Antônio Lúcio; Barbosa, Maira Tonidandel; Santos, Ana Paula; Pellizzaro, Marcelo; Guimarães, Henrique Cerqueira; Beato, Rogério; Carlos, Bacino; Marra, Hellen; Santos, Etelvina Lucas dos; Fialho, Patrícia Paes Araujo; Machado, Thaís Helena; Carvalho, Viviane Amaral; Koenig, Anne M.; Almeida, Mariana Ramos; Fonseca, Simone Evangelista; Coutinho, Cerise F.A.; França, Elisa; Dezontini, Natali F.; Moreira, Clarissa V.; Maia, Débora Palma; Cunningham, Mauro Q.; Sakurai, Emília

doi:10.1016/j.jalz.2009.04.1037

Cited by 4 publications

(9 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Many studies were judged to have a high risk of bias regarding how closely representative the sample frame was to the target population (Banerjee et al, 2008;Caramelli et al, 2009;de Jager et al, 2017;Jacob et al, 2007;Llibre Rodriguez et al, 2008;Neita et al, 2014;Seby et al, 2011;Shaji et al, 1996Shaji et al, , 2005Tiwari et al, 2013;Van Der Poel et al, 2011;Vas et al, 2001), with studies failing to clearly report how they chose their sampling frame or selecting a frame out of convenience. Nonresponse bias was also frequently judged to constitute a high risk of bias, due to authors either not stating the study response rate or, when the response rate was low (<75%) whether there was any nonresponse bias (Banerjee et al, 2008(Banerjee et al, , 2017Bottino et al, 2008;Caramelli et al, 2009;Cesar et al, 2016;de Jager et al, 2017;Eldemire-Shearer et al, 2018;Gurukartick et al, 2016;Llibre Rodriguez et al, 2008;Lopes et al, 2012;Neita et al, 2014;Singh et al, 2008;Velazquez-Brizuela et al, 2014).…”

Section: External Validitymentioning

confidence: 99%

“…Both Jamaica and South Africa did not have any studies that were deemed as low risk of bias. The risk of bias assessments were upgraded to 'high risk' in several studies (Caramelli et al, 2009;Cesar et al, 2016;Magalhães et al, 2008) with a high prevalence of dementia in their sample (>15%), indicating that these estimates would likely change with the addition of new data.…”

Section: Accepted Manuscriptmentioning

confidence: 99%

See 1 more Smart Citation

A systematic review and meta-analysis of dementia prevalence in seven developing countries: A STRiDE project

Farina

Ibnidris

Alladi

et al. 2020

Global Public Health

View full text Add to dashboard Cite

show abstract

Section: External Validitymentioning

confidence: 99%

Section: Accepted Manuscriptmentioning

confidence: 99%

A systematic review and meta-analysis of dementia prevalence in seven developing countries: A STRiDE project

Farina

Ibnidris

Alladi

et al. 2020

Global Public Health

View full text Add to dashboard Cite

show abstract

“…Three sequelae and their respective disability weights derived from a systematic review of seven studies using the Clinical Dementia Rating (CDR) Scale: mild (CDR1), moderate (CDR2), or severe (CDR3) dementia 19 . All data on the prevalence, incidence, and association with AD and other dementias included Brazilian populationbased studies 7,8,9,10,11,12,13,14,15 to model the estimates. The data are available at http://ghdx.healthdata.org/gbd-2016/ data-input-sources.…”

Section: Methodsmentioning

confidence: 99%

“…The prevalence rates of dementia among patients aged 60 years or older in the cities of Ribeirão Preto 9 , São Paulo 10 , and Tremembé 11 were 12.5, 12.9, and 17.5%, respectively. In a small city in the state of Minas Gerais, the figure for those aged 75 years and older was 27.5% 12 . Incidence studies are scarce.…”

mentioning

confidence: 96%

Dementias in Brazil: increasing burden in the 2000–2016 period. Estimates from the Global Burden of Disease Study 2016

Melo

Champs²,

Goulart

et al. 2020

Arq. Neuro-Psiquiatr.

View full text Add to dashboard Cite

Introduction: Dementia is a globally relevant health problem, which places a great burden on patients and their families. This study aimed to estimate the burden associated with Alzheimer's disease (AD) and other dementias in Brazil. Methods: In this descriptive study, we investigated the estimates obtained by the Global Burden of Disease study. We described the prevalence of AD and other dementias, years lived with disability (YLDs), age-standardized mortality, years of life lost (YLLs), and disability-adjusted life years (DALYs) among individuals aged 60 years or older between 2000 and 2016, with their respective 95% uncertainty intervals (95%UI). Results: During this period, the age-standardized prevalence of AD and other dementias per 100,000 people increased by 7.8%, from 961.7 (95%UI 828.3–1,117.5) to 1,036.9 (95%UI 882.0–1,219.5), with approximately 1.5 million people living with dementia in Brazil. The incidence increased by 4.5%. Similarly, all age-standardized rates had an upward trend (mortality: 3.1%; YLLs: 5.8%; YLDs: 7.9%; and DALYs: 6.3%). Mortality profiles increased with age in both years. Dementias were ranked fourth among the leading causes of death in people aged ≥70 years in 2000, rising to second place in 2016. In 2016, it also represented the second and third leading causes of disability among older women and men, respectively. Conclusion: Population growth and aging have resulted in an increased burden of AD and other dementias in Brazil. Preventive and early diagnostic measures are essential to mitigate the burden associated with these diseases.

show abstract

“…In the third phase, another independent sample consisting of 20 patients fulfilling the diagnosis of either possible or probable AD were randomly selected from among the demented subjects identified in a large population-based epidemiological survey, The PIETÀ study, 19 conducted in Caeté, Minas Gerais state, southeast Brazil. This study also has local ethics committee approval and all the participants gave written informed consent.…”

Section: Methodsmentioning

confidence: 99%

Brazilian caregiver version of the Apathy Scale

Guimarães

Fialho

Carvalho

et al. 2009

Dement. neuropsychol.

Self Cite

View full text Add to dashboard Cite

No Brazilian version of a specific scale for evaluating apathy in dementia is available.ObjectivesTo introduce a translated version of the Apathy Scale (AS) for use with caregivers.MethodsThe instrument was formally translated and then administered to the caregivers of a small sample of dementia patients, in order to assess scale comprehensibility and make final adjustments. The scale was subsequently administered to the caregivers of a second, independent sample of Alzheimer’s disease (AD) patients. The content validity of the scale was tested by correlating the AS scores with the Neuropsychiatric Inventory (NPI) - apathy sub-score and Disability Assessment in Dementia (DAD) total scores.ResultsThe first sample consisted of eleven subjects with dementia, most of whom had AD. The second sample comprised twenty patients with probable or possible AD (10 with mild dementia), a mean age of 84.1±5.8 years, and 2.2±1.6 years of schooling. The AS scores correlated with both NPI-apathy sub-score (r=0.756, p=0.001) and DAD total scores (r=–0.793, p=0.0005).ConclusionsThe final version had good comprehensibility and correlated strongly with standardized apathy and functional activities of daily living measures.

show abstract

P3‐163: Prevalence of cognitive impairment and dementia in a cohort of oldest old in Brazil: The Pietà study

Cited by 4 publications

References 0 publications

A systematic review and meta-analysis of dementia prevalence in seven developing countries: A STRiDE project

A systematic review and meta-analysis of dementia prevalence in seven developing countries: A STRiDE project

Dementias in Brazil: increasing burden in the 2000–2016 period. Estimates from the Global Burden of Disease Study 2016

Brazilian caregiver version of the Apathy Scale

Contact Info

Product

Resources

About